60 degrees pharma provides university of kentucky with right of reference to arakoda® nda in support of sj733 phase iib study

60 degrees pharma grants u of kentucky a right of reference to arakoda® nda for a phase iib trial combining sj733 with tafenoquine to treat vivax malaria.

SXTP Ratings Summary

SXTP Quant Ranking